Delivery Order SPE2DR25D1017-SPE2DR26F9CGS
- Not listed
- The Defense Logistics Agency awarded a $4,939.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. The contract, which carries an ultimate completion date of January 14, 2026, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This procurement was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order valued at $4,939.58 to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors, with a completion date of January 15, 2026. This is a firm fixed-price, non-set-aside contract with performance executed from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $4,939.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. The contract, which is not set-aside, has an ultimate completion date of December 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $4,939.58 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen injectors on December 16, 2025, with an ultimate completion date of January 8, 2026. This firm fixed-price contract represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on June 10, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The products will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $9,879.12 to AmerisourceBergen Drug Corp for the supply of Tezspire 210 mg/1.91 ml pen injectors. This non-competitive, firm fixed-price delivery order was issued on December 29, 2025, with an ultimate completion date of January 21, 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents one of...
- The Defense Logistics Agency awarded a delivery order valued at $9,879.12 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen injectors, with an ultimate completion date of December 12, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors, with a ceiling value of $7,409.34 and a firm fixed price contract type. The order is set to be completed by December 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was awarded through open competition without a set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $4,687.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. The contract, which is not set-aside and competitively awarded, has an ultimate completion date of November 19, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors, with a contract ceiling value of $4,939.56 and an ultimate completion date of December 10, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a delivery order under a larger contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CGSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,939.58 to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of January 22, 2026, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. Tezspire is a biologic medication used in the treatment of severe eosinophilic asthma, reflecting the breadth of specialty medications available through this federal supply contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 12/29/25 |